Synthesis and In Vitro (Anticancer) Evaluation of eta(6)-Arene Ruthenium Complexes Bearing Stannyl Ligands

Olivier Renier, Connor Deacon-Price, Joannes E. B. Peters, Kunsulu Nurekeyeva, Catherine Russon, Simba Dyson, Siyabonga Ngubane, Judith Baumgartner, Paul J. Dyson, Tina Riedel, Haleden Chiririwa, Burgert Blom*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number44
Number of pages13
JournalInorganics
Volume5
Issue number3
DOIs
Publication statusPublished - Sep 2017

Keywords

  • bioorganometallic chemistry
  • metal-based drugs
  • phosphorus ligands
  • ruthenium
  • half-sandwich complexes
  • tin dichloride insertion
  • PLATINUM COMPLEXES
  • METAL-COMPLEXES
  • CANCER
  • CHEMISTRY
  • DRUGS
  • CYTOTOXICITY
  • METALLODRUGS
  • DESIGN
  • KP1019
  • AGENTS

Cite this

Renier, O., Deacon-Price, C., Peters, J. E. B., Nurekeyeva, K., Russon, C., Dyson, S., Ngubane, S., Baumgartner, J., Dyson, P. J., Riedel, T., Chiririwa, H., & Blom, B. (2017). Synthesis and In Vitro (Anticancer) Evaluation of eta(6)-Arene Ruthenium Complexes Bearing Stannyl Ligands. Inorganics, 5(3), [44]. https://doi.org/10.3390/inorganics5030044